Project milestone: the MOSAIC study reaches 1,000 patients

We’re excited to announce we have now exceeded 1,000 patients with our partnering cancer research hospitals across Europe and the US.

Unlike similar studies, MOSAIC is both broad and deep, covering 7 cancer indications and 6 data modalities, including clinical and longitudinal data. By using 10XGenomics single-cell and spatial technologies on whole tissue sections, MOSAIC fully captures TME heterogeneity.

We believe that the synergy of large scale spatial omics data and AI will help us decode cancer complexity.